Molecular and idiotypic analyses of the antibody response to Cryptococcus neoformans glucuronoxylomannan-protein conjugate vaccine in autoimmune and nonautoimmune mice

Infect Immun. 1999 Sep;67(9):4469-76. doi: 10.1128/IAI.67.9.4469-4476.1999.

Abstract

The antibody response to Cryptococcus neoformans capsular glucuronoxylomannan (GXM) in BALB/c mice frequently expresses the 2H1 idiotype (Id) and is restricted in variable gene usage. This study examined the immunogenicity of GXM-protein conjugates, V (variable)-region usage, and 2H1 Id expression in seven mouse strains: BALB/c, C57BL/6, A/J, C3H, NZB, NZW, and (NZB x NZW)F(1) (NZB/W). All mouse strains responded to vaccination with GXM conjugated to tetanus toxoid (TT), the relative magnitude of the antibody response being BALB/c approximately C3H > C57BL/6 approximately NZB approximately NZW approximately NZB/W > A/J. Analysis of serum antibody responses to GXM with polyclonal and monoclonal antibodies to the 2H1 Id revealed significant inter- and intrastrain differences in idiotype expression. Thirteen monoclonal antibodies (MAbs) (two immunoglobulin M [IgM], three IgG3, one IgG1, three IgG2a, two IgG2b, and two IgA) to GXM were generated from one NZB/W mouse and one C3H/He mouse. The MAbs from the NZB/W mouse were all 2H1 Id positive (Id(+)) and structurally similar to those previously generated in BALB/c mice, including the usage of a V(H) from the 7183 family and Vkappa5.1. Administration of both 2H1 Id(+) and Id(-) MAbs from NZB/W and C3H/H3 mice prolonged survival in a mouse model of cryptococcosis. Our results demonstrate (i) that V-region restriction as indicated by the 2H1 Id is a feature of both primary and secondary responses of several mouse strains; and (ii) that there is conservation of V-region usage and length of the third complementarity-determining region in antibodies from three mouse strains. The results suggest that V-region restriction is a result of antibody structural requirements necessary for binding an immunodominant antigen in GXM.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • Antibodies, Fungal / immunology*
  • Antibodies, Monoclonal / immunology
  • Autoimmunity / immunology*
  • Base Sequence
  • Cryptococcus neoformans / immunology*
  • DNA, Complementary
  • Female
  • Fungal Vaccines / immunology*
  • Immunoglobulin Idiotypes / immunology*
  • Immunoglobulin Variable Region / immunology
  • Lupus Erythematosus, Systemic / immunology
  • Mice
  • Mice, Inbred C3H
  • Mice, Inbred Strains
  • Molecular Sequence Data
  • Polysaccharides / immunology*
  • Rabbits
  • Tetanus Toxoid / immunology*
  • Vaccines, Conjugate / immunology

Substances

  • Antibodies, Fungal
  • Antibodies, Monoclonal
  • DNA, Complementary
  • Fungal Vaccines
  • Immunoglobulin Idiotypes
  • Immunoglobulin Variable Region
  • Polysaccharides
  • Tetanus Toxoid
  • Vaccines, Conjugate
  • glucuronoxylomannan

Associated data

  • GENBANK/AF093549
  • GENBANK/AF093550
  • GENBANK/AF093551
  • GENBANK/AF093552
  • GENBANK/AF093553
  • GENBANK/AF093554
  • GENBANK/AF093555
  • GENBANK/AF093556
  • GENBANK/AF093557
  • GENBANK/AF093558
  • GENBANK/AF093559
  • GENBANK/AF093560
  • GENBANK/AF093561
  • GENBANK/AF093562
  • GENBANK/AF093563
  • GENBANK/AF093564
  • GENBANK/AF128260
  • GENBANK/AF128261
  • GENBANK/AF128262
  • GENBANK/AF128263
  • GENBANK/AH007225
  • GENBANK/AH007270
  • GENBANK/AH007271